Stumbles plague Boston Scientific

[Minnesota Public Radio, March 16, 2010] Heart device manufacturer Boston Scientific's financial struggles have been exacerbated by news this week that shipments of its implantable cardioverter defibrillators, or ICDs, have been halted for failure to get approval of manufacturing changes on the devices.

As word of Boston Scientific's news circulated, it did not appear to cause alarm at the Minneapolis Heart Institute. "This is not disruptive," said senior cardiologist Robert Hauser. Hauser wasn't sure if any surgery plans would have to be changed in the short term to accommodate Boston Scientific's moratorium on use of their implantable defibrillators. He said if the hold continued for a long time, it could cause problems, but he doubts that will happen. Listen to the story below and read more on

Share this article